Clinical Trials Logo

Sleep Disorder, Intrinsic clinical trials

View clinical trials related to Sleep Disorder, Intrinsic.

Filter by:
  • None
  • Page 1

NCT ID: NCT00631657 Completed - Mental Disorders Clinical Trials

A 6-Month Efficacy and Safety Study of Org 50081 in Adult Patients With Chronic Primary Insomnia (21106/P05701/MK-8265-002)

Start date: March 4, 2008
Phase: Phase 3
Study type: Interventional

To investigate the long-term efficacy and safety of treatment with esmirtazapine (Org 50081, SCH 900265, MK-8265) compared to placebo, in participants with chronic primary insomnia. Primary efficacy variable is Total Sleep Time (TST).

NCT ID: NCT00561574 Completed - Mental Disorder Clinical Trials

A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001)

Jade
Start date: January 9, 2008
Phase: Phase 3
Study type: Interventional

The current study is a 52-week safety study in elderly outpatients with chronic primary insomnia randomized to treatment with 1.5 mg or 3.0 mg of esmirtazapine (Org 50081, SCH 900265, MK-8265) to investigate the safety and tolerability of long-term treatment with esmirtazapine in elderly patients.